Search research articles
Contact Us
Filters
Showing results (371-380 of 401) with videos related to
Page
of 41
Sort By:
Computers in Biology and Medicine
|
May 1, 2018
Eliminating artifacts in single-grid phase-contrast x-ray imaging for improving image quality
H W Lee, H W Lim, D H Jeon, et al.
Diabetes, Obesity & Metabolism
|
December 6, 2014
Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial
M K Kim, E-J Rhee, K A Han, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2019
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
S T Kim, J H Kang, J Lee, et al.
Diabetes, Obesity & Metabolism
|
October 28, 2010
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes
E J Rhee, W Y Lee, K H Yoon, et al.
Cell Death & Disease
|
February 15, 2014
Suppression of tumor angiogenesis by targeting the protein neddylation pathway
W-T Yao, J-F Wu, G-Y Yu, et al.
Oncogene
|
March 16, 2010
Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer
K-S Lee, Y-S Lee, J-M Lee, et al.
Virology Journal
|
March 22, 2024
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
Samuel M S Cheng, Chris K P Mok, John K C Li, et al.
ESMO Open
|
September 18, 2025
Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)
S Hwang, M H Hong, S H Shin, et al.
Alimentary Pharmacology & Therapeutics
|
February 16, 2018
Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
T Karlas, D Petroff, M Sasso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients
S J Seong, M Lim, S K Sohn, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 401) with videos related to
Sort By:
Page
of 41
Computers in Biology and Medicine
|
May 1, 2018
Eliminating artifacts in single-grid phase-contrast x-ray imaging for improving image quality
H W Lee, H W Lim, D H Jeon, et al.
Diabetes, Obesity & Metabolism
|
December 6, 2014
Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial
M K Kim, E-J Rhee, K A Han, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 21, 2019
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
S T Kim, J H Kang, J Lee, et al.
Diabetes, Obesity & Metabolism
|
October 28, 2010
A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes
E J Rhee, W Y Lee, K H Yoon, et al.
Cell Death & Disease
|
February 15, 2014
Suppression of tumor angiogenesis by targeting the protein neddylation pathway
W-T Yao, J-F Wu, G-Y Yu, et al.
Oncogene
|
March 16, 2010
Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer
K-S Lee, Y-S Lee, J-M Lee, et al.
Virology Journal
|
March 22, 2024
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
Samuel M S Cheng, Chris K P Mok, John K C Li, et al.
ESMO Open
|
September 18, 2025
Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)
S Hwang, M H Hong, S H Shin, et al.
Alimentary Pharmacology & Therapeutics
|
February 16, 2018
Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
T Karlas, D Petroff, M Sasso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients
S J Seong, M Lim, S K Sohn, et al.
Page
of 41